Track topics on Twitter Track topics that are important to you
GlaxoSmithKline are set to make redundancies at their site in Stevenage. The move comes as the firm takes “a new approach to research and development,” in focusing more strongly on “transformational medicines.”
Original Article: GSK to make redundancies at plant in StevenageNEXT ARTICLE
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...